Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GOODRX HOLDINGS, INC.

(GDRX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
25.56(c) 25.04(c) 23.51(c) 24.23(c) 23.95(c) Last
1 384 709 1 606 637 1 422 367 1 874 046 1 685 342 Volume
-1.31% -2.03% -6.11% +3.06% -1.16% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 749 M - -
Net income 2021 19,8 M - -
Net cash position 2021 281 M - -
P/E ratio 2021 533x
Yield 2021 -
Sales 2022 1 018 M - -
Net income 2022 76,8 M - -
Net cash position 2022 467 M - -
P/E ratio 2022 137x
Yield 2022 -
Capitalization 9 553 M 9 553 M -
EV / Sales 2021 12,4x
EV / Sales 2022 8,93x
Nbr of Employees 462
Free-Float -
More Financials
Company
GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and... 
Sector
Internet Services
Calendar
03/10Earnings Release
More about the company
Ratings of GoodRx Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about GOODRX HOLDINGS, INC.
01/25Deutsche Bank Adjusts GoodRx Holdings' Price Target to $25 From $44, Maintains Hold Rat..
MT
01/07Credit Suisse Lowers GoodRx Holdings' Price Target to $41 from $52, Maintains Outperfor..
MT
01/07Goldman Sachs Starts GoodRx Holdings at Buy With $43 Price Target
MT
01/05Baird Adjusts Price Target on GoodRx Holdings to $34 From $40; Neutral Rating Kept
MT
01/05INSIDER SELL : Goodrx Holdings
MT
01/04GoodRx to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
BU
2021INSIDER SELL : Goodrx Holdings
MT
2021GoodRx Shares Rise After Stephens Starts It at Overweight
MT
2021Stephens Starts GoodRx Holdings at Overweight With $45 Price Target
MT
2021INSIDER SELL : Goodrx Holdings
MT
2021Morgan Stanley Adjusts GoodRx Holdings' Price Target to $41 from $38, Keeps Equalweight..
MT
2021Wheel Announces Integration with GoodRx to Help Millions of Patients Follow Treatment P..
CI
2021Veru Receives FDA Approval for Entadfi for Benign Prostatic Hyperplasia; Stock Climbs
MT
2021Veru Shares Up After FDA Approves Entadfi in Benign Prostatic Hyperplasia
DJ
2021INSIDER SELL : Goodrx Holdings
MT
More news
News in other languages on GOODRX HOLDINGS, INC.
01/21IBM verkauft Watson-Teile an Investmentfirma
2021Les actions de GoodRx augmentent après que Stephens l'ait placé en surpondération.
2021VENTE PAR DES INITIÉS : Goodrx Holdings
2021Veru reçoit l'approbation de la FDA pour Entadfi dans le traitement de l'hyperplasie bé..
2021VENTE PAR DES INITIÉS : Goodrx Holdings
More news
Analyst Recommendations on GOODRX HOLDINGS, INC.
More recommendations
Chart GOODRX HOLDINGS, INC.
Duration : Period :
GoodRx Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GOODRX HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 23,95 $
Average target price 42,25 $
Spread / Average Target 76,4%
EPS Revisions
Managers and Directors
Douglas Joseph Hirsch Co-Chief Executive Officer & Director
Trevor Bezdek Director
Karsten Voermann Chief Financial Officer
Christopher Adams Independent Director
Dipanjan DJ Deb Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GOODRX HOLDINGS, INC.-26.71%9 553
TENCENT HOLDINGS LIMITED2.19%571 560
PROSUS N.V.-5.21%200 632
NETFLIX, INC.-39.18%162 307
AIRBNB, INC.-13.17%90 522
UBER TECHNOLOGIES, INC.-16.96%67 555